Steven M Horwitz (Steven Horwitz, S Horwitz)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 22

Top Topics

Peritoneal Dialysis

Decision Making

Diffuse Large B Cell Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Neha Mehta-Shah, Steven M Horwitz
Failing Forward in Peripheral T-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Neha Mehta-Shah, Steven M Horwitz
Failing Forward in Peripheral T-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Neha Mehta-Shah, Steven M Horwitz
Failing Forward in Peripheral T-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Steven M Horwitz, Ajit J Nirmal, Jahan A Rahman, Ran Xu, Esther Drill, Natasha Galasso, Nivetha Ganesan, Theresa Davey, Helen Hancock, Leslie Perez, Catherine Maccaro, Alexandra Bahgat, Evan Marzouk, Elizabeth Cathcart, Alison Moskowitz, Ariela Noy, Anita Kumar, Eric Jacobsen, David C Fisher, Neha Mehta-Shah, Youn H Kim, Michael Khodadoust, Nikita Kotlov, Anastasia Nikitina, Olga Mikhaylovna Plotnikova, Valeria Zubareva, Ksenia Zornikova, Nara Shin, Maria A Sorokina, Sandrine Degryse, Ekaterina Postovalova, Aleksander Bagaev, Kinga K Hosszu, Devin McAvoy, Jaap-Jan Boelens, Wenchao Wu, Zoe Ciantra, Jackson W Appelt, Christopher Trevisani, Sam Amaka, David M Weinstock, Santosha A Vardhana
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial. Nature medicine (2024)
M Civallero, Joseph G Schroers-Martin, Steven M Horwitz, M Manni, Yana Stepanishyna, M E Cabrera, J Vose, M Spina, F Hitz, Arnon Nagler, S Montoto, C Chiattone, T Skrypets, M A Perez Saenz, G Priolo, Stefano Luminari, A Lymboussaki, Astrid Pavlosky, D Marino, Anna Marina Liberati, Judith Trotman, D Mannina, M Federico, Ranjana H Advani
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project. British journal of haematology (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Neha Mehta-Shah, Steven M Horwitz
Failing Forward in Peripheral T-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Monica Civallero, Joseph G Schroers-Martin, Steven M Horwitz, Martina Manni, Yana Stepanishyna, Maria Elena Cabrera, Julie Vose, Michele Spina, Felicitas Hitz, Arnon Nagler, Silvia Montoto, Carlos Chiattone, Tetiana Skrypets, M Angeles Perez Saenz, Giorgio Priolo, Stefano Luminari, Athina Lymboussaki, Astrid Pavlosky, Dario Marino, Anna Marina Liberati, Judith Trotman, Donato Mannina, Massimo Federico, Ranjana H Advani
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project. British journal of haematology 205 (1) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Neha Mehta-Shah, Steven M Horwitz
Failing Forward in Peripheral T-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Michael J Buege, Esther Drill, Steven M Horwitz, Andréa LeVoir, Terry Pak, Tim J Peterson, Phuong H Dao, Matthew J Matasar
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure. European journal of haematology (2023)
Gongwei Wu, Noriaki Yoshida, Jihe Liu, Xiaoyang Zhang, Yuan Xiong, Tayla B Heavican-Foral, Elisa Mandato, Huiyun Liu, Geoffrey M Nelson, Lu Yang, Renee Chen, Katherine Aleisha Donovan, Marcus Kenneth Jones, Mikhail Roshal, Yanming Zhang, Ran Xu, Ajit J Nirmal, Salvia Jain, Catharine Leahy, Kristen L Jones, Kristen E Stevenson, Natasha Galasso, Nivetha Ganesan, Tiffany Chang, Wen-Chao Wu, Abner Louissaint, Lydie Debaize, Hojong Yoon, Paola Dal Cin, Wing C Chan, Shannan Ho Sui, Samuel Y Ng, Andrew L Feldman, Steven M Horwitz, Karen Adelman, Eric S Fischer, Chun-Wei David Chen, David M Weinstock, Myles A Brown
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence. Science translational medicine 15 (714) (2023)
Robert N Stuver, Steven M Horwitz, Ranjana H Advani, Julie M Vose, Jee Hun Lee, Neha Mehta-Shah, Jasmine M Zain, Bradley Haverkos, Mary Jo Lechowicz, Alison J Moskowitz, Luu Q Pham, Elizabeth Leyden, Stephen M Ansell, Matthew A Lunning
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma. British journal of haematology (2023)
Laurence L de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Fend, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry Joane Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Esther Drill, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Samia Sohail, Alayna Santarosa, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Anita Kumar, Oscar B Lahoud, Connie Lee Batlevi, Paul Hamlin, David J Straus, Ildefonso Rodriguez-Rivera, Colette Owens, Philip Caron, Andrew M Intlekofer, Audrey Hamilton, Steven M Horwitz, Lorenzo Falchi, Erel Joffe, William T Johnson, Christina Lee, Maria Lia Palomba, Ariela Noy, Matthew J Matasar, Georgios Pongas, Gilles Andre Salles, Santosha A Vardhana, Beatriz Wills Sanin, Gottfried von Keudell, Joachim Yahalom, Ahmet Dogan, Andrew D Zelenetz, Craig H Moskowitz
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (28) (2021)
Anita Kumar, Carla Casulo, Ranjana H Advani, Elizabeth Budde, Paul M Barr, Connie Lee Batlevi, Philip Caron, Louis S Constine, Savita V Dandapani, Esther Drill, Pamela Drullinsky, Jonathan W Friedberg, Clare Grieve, Audrey Hamilton, Paul A Hamlin, Richard T Hoppe, Steven M Horwitz, Ashlee Joseph, Niloufer Khan, Leana Laraque, Matthew J Matasar, Alison J Moskowitz, Ariela Noy, Maria Lia Palomba, Heiko Schöder, David J Straus, Shreya Vemuri, Joanna Yang, Anas Younes, Andrew D Zelenetz, Joachim Yahalom, Craig H Moskowitz
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (20) (2021)
Neha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, Alison J Moskowitz, Craig Sauter, Steven M Horwitz, Heiko Schöder
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma. Blood advances 3 (2) (2020)
Alexandra Gomez-Arteaga, Elizabeth M Margolskee, Mike Tzuhen Wei, Koen van Besien, Giorgio Inghirami, Steven M Horwitz
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation. Leukemia & lymphoma 60 (7) (2019)
Lauren E Latella, Madeline Rogers, Howard Leventhal, Patricia A Parker, Steven M Horwitz, Matthew J Matasar, Carma L Bylund, David W Kissane, Kara Franco, Smita C Banerjee
Fear of cancer recurrence in lymphoma survivors: A descriptive study. Journal of psychosocial oncology 38 (3) (2019)
Sven Borchmann, Erel Joffe, Craig H Moskowitz, Andrew D Zelenetz, Ariela Noy, Carol S Portlock, John F Gerecitano, Connie Lee Batlevi, Philip C Caron, Pamela Drullinsky, Audrey Hamilton, Paul A Hamlin, Steven M Horwitz, Anita Kumar, Matthew J Matasar, Alison J Moskowitz, Colette N Owens, Maria Lia Palomba, Anas Younes, David J Straus
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood 133 (20) (2019)
Alison J Moskowitz, Steven M Horwitz
mTOR inhibition in T-cell lymphoma: a path(way) forward. Blood 126 (3) (2015)